Symptoms Of Early Cancer Research Articles

Factors influencing delayed cancer health seeking in Meghalaya, Northeast India: A qualitative study

Background & objectives India accounts for about seven per cent of the global cancer burden with the highest cancer incidence reported from the North-Eastern Region (NER), including Meghalaya. Despite this, there is paucity of published studies on health seeking behaviour for cancer in the NER. To address this gap, this study used a qualitative approach to document patient, caregiver and provider perspectives to understand the factors influencing healthcare seeking for cancers in Meghalaya. Methods In-depth interviews were undertaken with 37 individuals diagnosed with one of the top five cancers in Meghalaya, namely, oesophageal, breast, oral, cervical and lung cancer. They were identified from the State referral cancer hospital. Twelve caregivers and five healthcare providers were also interviewed. All interviews were conducted in the local language using semi-structured interview guides. Transcripts were translated to English, coded, categorized and analyzed using thematic framework content analysis approach. Results A key factor influencing delayed cancer treatment in Meghalaya included misconceptions regarding the causes of cancer and cultural concepts such as bih and skai (Khasi language), i.e. notions of a figurative ‘poison’ or ill intent that makes one susceptible to illness. A general reluctance to discuss cancer diagnoses, perceived stigma, apprehension of treatment methods influenced their decision. Other factors included negligence and misinterpretation of early symptoms of cancer, self-management, preference for traditional medicines, financial constraints and health system-related factors. Interpretation & conclusions This study underscores the importance of addressing barriers to cancer diagnosis and treatment in indigenous populations in northeast India, advocating for culturally appropriate messaging, capacity building for healthcare workers, integration of traditional healers, and community involvement to enhance early healthcare seeking and improve outcomes.

An innovative breast cancer detection framework using multiscale dilated densenet with attention mechanism

ABSTRACT Cancer-related deadly diseases affect both developed and underdeveloped nations worldwide. Effective network learning is crucial to more reliably identify and categorize breast carcinoma in vast and unbalanced image datasets. The absence of early cancer symptoms makes the early identification process challenging. Therefore, from the perspectives of diagnosis, prevention, and therapy, cancer continues to be among the healthcare concerns that numerous researchers work to advance. It is highly essential to design an innovative breast cancer detection model by considering the complications presented in the classical techniques. Initially, breast cancer images are gathered from online sources and it is further subjected to the segmentation region. Here, it is segmented using Adaptive Trans-Dense-Unet (A-TDUNet), and their parameters are tuned using the developed Modified Sheep Flock Optimization Algorithm (MSFOA). The segmented images are further subjected to the breast cancer detection stage and effective breast cancer detection is performed by Multiscale Dilated Densenet with Attention Mechanism (MDD-AM). Throughout the result validation, the Net Present Value (NPV) and accuracy rate of the designed approach are 96.719% and 93.494%. Hence, the implemented breast cancer detection model secured a better efficacy rate than the baseline detection methods in diverse experimental conditions.

Public perceptions of families affected by pediatric cancer and educational work in pediatric oncology.

This study aims to explore how Russian society perceives children with cancer and their families to determine its potential as a tool for solving the social struggles of cancer-affected youth. The study took place between 2019 and 2020 and involved 237 parents of cancer-affected children enrolled for inpatient treatment in 5 pediatric oncology clinics in the North Caucasus Federal District (Russia). The study exploits a specially designed questionnaire survey as its main research method. About half of the parents did not observe changes in their attitude towards their child following a cancer diagnosis, with women more frequently noting these changes (40% vs. 18%). Public sentiment diverges between poles of sympathy and alienation: 53% acknowledge the expression of sympathy, while 39% perceive a sense of alienation. This study underscores the imperative for adequate support for these families, encompassing both financial and social dimensions. The present findings can be used to design cancer awareness and anti-stigma programs aimed at educating the general population about the early symptoms of cancer, where to receive health consultation services, how to talk with and act around cancer-affected children, and how to support such children and their families. Despite advances in modern medicine and multiple cases of pediatric cancer being successfully treated, stereotypes about the incurable nature of cancer still exist in many countries. The present findings can serve as a platform for the comparative study of cancer-related issues in other regions and countries. The results of this study can also be used to design cancer awareness and anti-stigma programs aimed at educating the general population about the early symptoms of cancer, where to receive health consultation services, how to talk with and act around cancer-affected children, and how to support such children and their families.

Leveraging the Application of IoT based Deep Learning Prediction Model in Smart Healthcare

The standard IoT sensors and tools are to learn data construction techniques for creating a predictive model.The use of time series evaluation tools to identify thyroid tumors in their early stages is examined in this research. The records of thyroid ultrasound scans from 475 individuals are examined. The analysis is utilized to evaluate the predictor model's accuracy and the Time Series evaluation methodologies' suitability for correctly identifying thyroid cancer in its early stages. The results demonstrate the effectiveness of time-collection analytic techniques in the early detection of thyroid cancer. The results also highlight the potential for utilizing time series analytic techniques in various cancer-related early detection initiatives. The majority of thyroid tumors were found at an early stage using time series analysis, a finding that is the focus of this technical report. The program developed the ability to distinguish between benign and malignant tumors. The results of the observation demonstrated that the set of guidelines was effective in increasing the precision degree measurement using various wearable IoT Sensors. Additionally, the set of guidelines can identify the presence of a tumor before any scientific symptoms are apparent. The observer concluded that time-collecting analysis might be utilized to identify early cancer symptoms, which would undoubtedly lead to improved outcomes and more advanced treatments.

Trajectories to a cancer diagnosis: Why and when women seek help for breast symptoms in Vietnam.

Women in low- and middle-income countries where the prevalence and mortality of breast cancer are growing rapidly are more likely to be diagnosed at advanced stages, which negatively affects their treatment outcomes and chance of survival. The current literature in those settings tends to focus largely on explaining patient delay in seeking medical attention for breast symptoms. Meanwhile, little is known as to what prompts women to attend screening and diagnostic services after discovering symptomatic breasts. Drawn upon the data from in-depth interviews with 33 breast cancer patients in Central Vietnam conducted in 2019, this paper examines the context of women's decisions about breast screening and how the practice of seeking cancer diagnosis occurred. Our findings reveal an absence of a national screening program and that seeking medical advice was conducted on an ad hoc basis after self-detection of breast symptoms. Women's interpretations of symptomatic breasts as suspicious signs of cancer, the co-occurrence of important life events, or encouragement by people in their social network motivated women to seek medical attention at different public and private health facilities. Their encounters with the health sector often involved multiple visits across time and space in which they experienced various forms of diagnosis delay produced by the health system. Our study carries implications for interventions to encourage women's awareness of early cancer symptoms and prompt medical presentation after self-discovery of symptomatic breasts.

An ultrasensitive approach for cancer screening and tissue of origin prediction based on targeted methylation sequencing of cell-free DNA.

10553 Background: Cancer-specific therapy requires the identification of the tumor origin. Detecting cancer and identifying the tumor origin in early stage can improve the survival and prognosis of cancer patients. However, early diagnosis of cancer is challenging as the early symptoms of cancer are mild or even absent. In order to improve the diagnostic efficacy and the patient compliance, we developed a two-stage model for cancer diagnosis and tissue of origin (TOO) classification, using DNA methylation profile evaluated through non-invasive blood-based testing as biomarker. Methods: cfDNA samples from 302 healthy and 598 cancer patients of 8 cancer types (colorectal, lung, liver, pancreatic, gastric, esophagus, breast and ovarian) were sequenced by our in-house-designed DNA methylation panel and randomly split into a training dataset (213:426) and a testing dataset (89:172). The testing dataset was reserved to evaluate the performance of models and would not be used during the feature selection and model development process. Methylation levels of cfDNA samples were measured by the methylated fragment ratios (MFRs) in methylated-correlated blocks (MCBs). We first selected pan-cancer markers by comparing the MFR values of MCBs between the healthy and the diseased individuals and developed a binary classifier (hyper-methylation score). Sample correctly predicted by the hyper-methylation score in the cancer group were then used for TOO marker selection and model fitting. TOO biomarkers were obtained by a series of pairwise comparisons of MFR values between any two cancer types. A deconvolution model was built to estimate the composition of ctDNA, which implied the tumor origin. Results: The hyper-methylation score model based on 135 MCB biomarkers achieved an area under the curve (AUC) of 0.89 in the training dataset and 0.85 in the testing dataset. Under a specificity of 94.8%, sensitivity was 66.2% in the training dataset. Using the 282 cases successfully being predicted, 583 TOO markers were selected to build the deconvolution model. In the testing dataset, the specificity was 95.5%, and the overall sensitivity was 66.3%. With increasing stage, sensitivity increased in all cancer types: 34.6%, 57.1%, 62.5% and 84.8% in stage I, II, III and IV respectively. In stage I-III, sensitivity was 52.3%. TOO classes were predicted in the 114 true positives from the hyper-methylation score model, producing a top 1 accuracy (true class matched the most probable class) of 75.4% and a top 2 accuracy (true class matched the first or the second most probable class) of 84.2%. Top 1 accuracy was 71.1% in stage I-III, vs. 84.0% in stage IV. Top 2 accuracy was 82.2% in stage I-III, vs. 90.0% in stage IV. Conclusions: Our cfDNA-based epigenetic method achieved outstanding performance either in pan-cancer detection or in TOO classification, and is a promising tool for early-stage cancer diagnosis.

The Applications of Gold Nanoparticles in the Diagnosis and Treatment of Gastrointestinal Cancer.

In recent years, the morbidity and mortality of gastrointestinal cancer have remained high in China. Due to the deep location of the gastrointestinal organs, such as gastric cancer, the early symptoms of cancer are not obvious. It is generally discovered at an advanced stage with distant metastasis and lymph node infiltration, making it difficult to cure. Therefore, there is a significant need for novel technologies that can effectively diagnose and treat gastrointestinal cancer, ultimately reducing its mortality. Gold nanoparticles (GNPs), a type of nanocarrier with unique optical properties and remarkable biocompatibility, have the potential to influence the fate of cancer by delivering drugs, nucleic acids to cancer cells and tissues. As a safe and reliable visualization agent, GNPs can track drugs and accurately indicate the location and boundaries of cancer, opening up new possibilities for cancer treatment. In addition, GNPs have been used in photodynamic therapy to deliver photosensitizers, as well as in combination with photothermal therapy. Therefore, GNPs can be used as a safe and effective nanomaterial in the treatment and diagnosis of gastrointestinal cancer.

What factors empower general practitioners for early cancer diagnosis? A 20-country European Delphi Study.

Some symptoms are recognised as red flags for cancer, causing the General Practitioner (GP) to refer the patient for investigation without delay. However, many early symptoms of cancer are vague and unspecific, and in these cases, a delay in referral risks a diagnosis of cancer that is too late. Empowering GPs in their management of patients that may have cancer is likely to lead to more timely cancer diagnoses. To identify the factors that affect European GPs' empowerment in making an early diagnosis of cancer. This was a Delphi study involving GPs in 20 European countries. We presented GPs with 52 statements representing factors that could empower GPs to increase the number of early cancer diagnoses. Over three Delphi rounds, we asked GPs to indicate the clinical relevance of each statement on a Likert scale.The final list of statements indicated those that were considered by consensus to be the most relevant. In total, 53 GPs from 20 European countries completed the Delphi process, out of the 68 GPs who completed round one. Twelve statements satisfied the pre-defined criteria for relevance. Five of the statements related to screening and four to the primary/secondary care interface. The other selected statements concerned information technology (IT) and GPs' working conditions. Statements relating to training, skills and working efficiency were not considered priority areas. GPs consider that system factors relating to screening, the primary-secondary care interface, IT and their working conditions are key to enhancing their empowerment in patients that could have cancer. These findings provide the basis for seeking actions and policies that will support GPs in their efforts to achieve timely cancer diagnosis.

Diagnosing cancer during the COVID-19 pandemic: a retrospective cohort study from a public safety net referral institution

Diagnosing cancer during the COVID-19 pandemic: a retrospective cohort study from a public safety net referral institution

Knowledge and Beliefs of Cancer Risk Factors and Early Cancer Symptoms in Lebanon: A Cross-sectional Survey Among Adults in the Community.

BackgroundLebanon has an increasing cancer burden. Sufficient knowledge of cancer risk factors and early cancer symptoms can help lower cancer burden by facilitating primary prevention and early diagnosis. This study (i) assessed Lebanese adults’ knowledge and beliefs of cancer risk factors and early cancer symptoms, (ii) analyzed whether knowledge was correlated with personal behavior, and (iii) assessed the presence of barriers that keep knowledge from turning into healthcare seeking behavior.MethodsWe performed a cross-sectional survey in the Lebanese adult population, consisting of a questionnaire administered during face-to-face interviews on a community-based non-probability sample (n = 726) that was frequency matched to national government estimates on age, level of education and gender.ResultsRecognition was high for carcinogens and protective factors (75%), but low for neutral factors (22%) which were often seen as carcinogenic. A quarter of participants (27.8%) could not name any early warning signs. For some risk factors, high knowledge scores were correlated with low-risk behavior, but this was not the case for cigarette smoking. The most frequent barriers for not seeking timely care were financial (57.0%) fear of finding illness (53.7%), and having other things to worry about (42.4%).ConclusionThis study revealed important knowledge gaps which are likely to hamper primary prevention and early diagnosis. However, we also showed that high knowledge of risk was not always correlated with low-risk behavior. This, together with the barriers we found that kept people from seeking timely health care, emphasizes that efforts to lower cancer burden should not only focus on increasing knowledge.

Community cancer awareness programs: symptom awareness alone doesn’t suffice

Background: Although cancer is a global public health problem, maximum impact is on developing economies. In India, socio-cultural factors also operate to add the burden. Aim of the study was to delineate factors causing late presentation of cancers to the point of care.Methods: We gave cancer awareness classes to a village community, preceded by a campaign to attend the classes with the help of a local trustee organisation and primary health center. Data was collected from the attendees using a structured questionnaire prepared to dissect out the awareness about cancer symptoms and concerns about treatment.Results: Only 1.8% of the total population of the area under study attended the classes. Out of the 411 attendees, 323 (78.6%) responded to the questionnaire and of them, 294 (91%) identified the site wise symptoms of cancer clearly and 40 (12.4%) detected their own symptoms warranting cancer screening. Commonest concern was the cost of treatment (40.9%). There were people thinking that cancer is not a life-style disease (3.1%), it is genetic (7.7%), it may be due to fate alone (6.2%), it is contagious (5%), and it cannot be cured (3.7%).Conclusions: Despite high health status indices, literacy rate and high knowledge about cancer symptoms, there are still a lot of superstitions about cancer in Kerala. The most common reason preventing people from approaching health care system with early symptoms of cancer is the fear of cost of treatment. Apart from teaching symptoms of cancer, cancer awareness programs should include familiarisation of various financial aids available for cancer treatment.

Flexible Modeling of the Association Between Cumulative Exposure to Low-Dose Ionizing Radiation From Cardiac Procedures and Risk of Cancer in Adults With Congenital Heart Disease.

Adults with congenital heart disease are increasingly being exposed to low-dose ionizing radiation (LDIR) from cardiac procedures. In a recent study, Cohen et al. (Circulation. 2018;137(13):1334-1345) reported an association between increased LDIR exposure and cancer incidence but did not explore temporal relationships. Yet, the impact of past exposures probably accumulates over years, and its strength may depend on the amount of time elapsed since exposure. Furthermore, LDIR procedures performed shortly before a cancer diagnosis may have been ordered because of early symptoms of cancer, raising concerns about reversal causality bias. To address these challenges, we combined flexible modeling of cumulative exposures with competing-risks methodology to estimate separate associations of time-varying LDIR exposure with cancer incidence and all-cause mortality. Among 24,833 patients from the Quebec Congenital Heart Disease Database, 602 had incident cancer and 500 died during a follow-up period of up to 15 years (1995-2010). Initial results suggested a strong association of cancer incidence with very recent LDIR exposures, likely reflecting reverse causality bias. When exposure was lagged by 2 years, an increased cumulative LDIR dose from the previous 2-6 years was associated with increased cancer incidence, with a stronger association for women. These results illustrate the importance of accurate modeling of temporal relationships between time-varying exposures and health outcomes.

Do pharmacists contribute to patients' management of symptoms suggestive of cancer: a qualitative study.

Limited awareness of cancer symptoms results in patient delay in seeking help and contributes to delay in diagnosis. Few UK studies have investigated the potential for community pharmacists to facilitate earlier detection of cancer. This study aimed to investigate what actions patients take to manage their early cancer symptoms, to identify the extent of current community pharmacy involvement and to consider the potential role for community pharmacists to facilitate appropriate management and appraisal of potential early cancer symptoms. Patients diagnosed with lung, colorectal or gastro-oesophageal cancer in the preceding 12months were identified during clinic visits by consultants. Semi-structured interviews were conducted, audio-recorded, transcribed and thematically analysed, using the Framework Approach. Twenty-five consenting patients were interviewed: two-thirds were male and more than half had lung cancer. Although all had experienced potential cancer symptoms prior to diagnosis, most underestimated seriousness and misattributed causation. Symptoms were managed by lifestyle changes and self-selecting medicines from local shops, supermarkets and pharmacies but without engaging with the pharmacist. For symptom management, participants self-selected medicines from community pharmacies, but pharmacy staff were rarely involved. Involving community pharmacists or their staff at the point of sale of these medicines might have facilitated earlier cancer diagnosis. Further research is needed to quantify how many patients with symptoms suggestive of cancer present in community pharmacies to understand if a pharmacist's role in facilitating symptom management and appraisal of potential cancer symptoms would be acceptable and effective, before developing any interventions.

Demora en el diagnóstico y tratamiento del cáncer en el Perú. Estudio de 1,000 casos

Mil casos consecutivos de cáncer probados histológicamente, vistos en el Instituto Nacional de Enfermedades Neoplásicas en el período de un año, han sido estudiados y la responsabilidad por parte del paciente y del médico en la demora en el diagnóstico y tratamiento ha sido establecida. La principal causa de demora en el diagnóstico ha tenido como causa la responsabilidad del paciente, 60.9 por ciento. La ignorancia por parte del paciente ha sido la causa principal en su demora, 94 .7 por ciento. La demora por parte del médico, 25 .7 por ciento, es atribuida principalmente al hecho de que el carcinoma no fue sospechado y como consecuencia no se verificaron apropiados estudios para establecer un diagnóstico. Negligencia, exámenes inadecuados y recomendaciones equivocadas fueron las principales razones en la demora. Un individuo que tuvo síntomas por tres o más meses antes de su consulta al médico o consultó a un médico antes de este penado de tiempo y no pudo tener un diagnóstico o tratamiento adecuado, ha perdido un tiempo valioso. En nuestra serie 745 pacientes o sea 74.5 por ciento sufrieron de esta demora. La responsabilidad del médico para hacer un diagnóstico temprano, no sólo es limitado a los cánceres inaccesibles donde el diagnóstico no requiere exámenes especiales, sino también a los cánceres accesibles, probablemente porque el médico no sospecha o no interpreta los signos y síntomas del cáncer inicial. Por este estudio resulta obvio la imperiosa necesidad de una mejora en el diagnóstico temprano del cáncer, mediante la educación del paciente a través de una adecuada propaganda en el público y la difusión de los conocimientos del cáncer entre los médicos. Esta labor deberá ser llevada a cabo por las Escuelas de Medicina, las Sociedades Médicas y las Instituciones interesadas en el problema del cáncer.

Attributions of cancer 'alarm' symptoms in a community sample.

BackgroundAttribution of early cancer symptoms to a non-serious cause may lead to longer diagnostic intervals. We investigated attributions of potential cancer ‘alarm’ and non-alarm symptoms experienced in everyday life in a community sample of adults, without mention of a cancer context.MethodsA questionnaire was mailed to 4858 adults (≥50 years old, no cancer diagnosis) through primary care, asking about symptom experiences in the past 3 months. The word cancer was not mentioned. Target 'alarm' symptoms, publicised by Cancer Research UK, were embedded in a longer symptom list. For each symptom experienced, respondents were asked for their attribution (‘what do you think caused it'), concern about seriousness (‘not at all’ to ‘extremely’), and help-seeking (‘did you contact a doctor about it’: Yes/No).ResultsThe response rate was 35% (n = 1724). Over half the respondents (915/1724; 53%) had experienced an ‘alarm’ symptom, and 20 (2%) cited cancer as a possible cause. Cancer attributions were highest for ‘unexplained lump’; 7% (6/87). Cancer attributions were lowest for ‘unexplained weight loss’ (0/47). A higher proportion (375/1638; 23%) were concerned their symptom might be ‘serious’, ranging from 12% (13/112) for change in a mole to 41% (100/247) for unexplained pain. Just over half had contacted their doctor about their symptom (59%), although this varied by symptom. Alarm symptoms were appraised as more serious than non-alarm symptoms, and were more likely to trigger help-seeking.ConclusionsConsistent with retrospective reports from cancer patients, ‘alarm’ symptoms experienced in daily life were rarely attributed to cancer. These results have implications for understanding how people appraise and act on symptoms that could be early warning signs of cancer.

Nurses should be aware of the early symptoms of cancer

PUBLIC HEALTH It is important to look for the red flags which may indicate cancer, say Susanne Cruickshank and Victoria Harmer

Facilitators and barriers to help‐seeking for breast and cervical cancer symptoms: a qualitative study with an ethnically diverse sample in London

ObjectiveEarlier diagnosis of cancer has become a policy priority. There is evidence that minority ethnic groups are more likely to delay help-seeking for cancer symptoms, but few studies have explored reasons for delay in these groups. The present study explored facilitators and barriers to help-seeking for breast and cervical cancer in an ethnically diverse sample of women.MethodsSemi-structured interviews were carried out with 54 healthy women from a range of ethnic backgrounds; Indian, Pakistani, Bangladeshi, Caribbean, African, Black British, Black other, White British and White other. Framework analysis was used to identify themes.ResultsAppraising a symptom as possibly due to cancer was an important facilitator of help-seeking, although for some the prospect of a cancer diagnosis was a deterrent. Women believed that earlier diagnosis improved the chance of survival, and this facilitated prompt help-seeking. A sympathetic GP facilitated help-seeking, and an unsympathetic GP was a deterrent. Some ethnic minority women described the use of alternative medicine and prayer as a first-line strategy that might delay help-seeking. Language barriers, racism and a tendency to ‘soldier on’ were also mentioned by these women.ConclusionsModels of delay in presentation for early cancer symptoms are likely to transfer across different ethnic groups. Encouraging open discussion about cancer among minority communities could help raise awareness about the importance of early detection and promote help-seeking as a priority response to a possible cancer symptom. © 2013 The Authors. Psycho-Oncology published by John Wiley & Sons, Ltd.

Therapie des Magenkarzinoms

From a global perspective, gastric cancer including adenocarcinoma of the esophagogastric junction is the fourth most common malignant tumor and the second most common cause of cancer-related death. Due to the lack of specific symptoms of early cancer, most gastric cancers are diagnosed in advanced stages. Staging should include high-resolution computed tomography of the thorax, abdomen, and pelvis and documented video-endoscopy and endoscopic ultrasound. In mucosal gastric cancer, endoscopic resection can replace surgical resection. In more advanced stages, perioperative chemotherapy has been established as a standard of care. In the metastatic setting, treatment goals are palliative. Chemotherapy can prolong survival, improve symptoms, and enhance the quality of life. Combination chemotherapy including a platinum salt plus fluoropyrimidine is the standard of care. About 16 % of gastric cancers exhibit overexpression of the growth factor receptor HER2. Trastuzumab has shown to prolong survival when combined with chemotherapy in HER2-positive gastric cancer.

Embarrassment hinders UK patients seeking help over early cancer symptoms

Embarrassment hinders UK patients seeking help over early cancer symptoms

1457P - Control of Cancer in West Bengal, India by Screening and Awareness Program

ABSTRACT Background In India there are about 2.5 million cancer patients and it increases by 1 million new cancer patients every year, which is 1/10 of total cancer burden in the world. The aim of our state based non-governmental Cancer Control Program is to reduce the cancer burden by proper awareness and screening. We also intended to teach about the early symptoms of cancer so that it can be detected early to provide appropriate treatment. Our motto is to serve people residing in remote villages of West Bengal where there are no modern medical facilities available for detection of cancer. Material and methods During the period of January 2004–April 2012, a cancer screening & awareness program had been conducted in various districts of West Bengal, twice in every month by the members of NSCBCRI. We mainly dealt with oral, lung, breast and cervical cancer. We organized the awareness camps on a prefixed day with prior permission of the representatives. The cases which were detected positive were sent to our hospital for proper treatment and advanced cases were advised for pain and palliative treatment in our institution. Result More than 80% of people participated spontaneously in awareness camps. Female cancer incidence was about 60%. We observed tobacco habits in 80% of males & 10% of females. The percentage of passive smokers among females is very high in West Bengal. Among 144256 screened population, we found 11541 (8.0%) cancer patients in different stages of the disease. Ratio of male and female patients was 3:2. A total of 4986 (72%) male and 1200 (26%) female cancers were tobacco related. Among females the incidence of cervical and breast cancer were 34% and 23%, respectively. Among male oral and lung cancer incidence were 32% and 35%, respectively. About 67% of the cancer had been detected at an early stage. Conclusion Through camps in remote rural areas of West Bengal we came to know that the majority of cancer cases are life style related. This can only be prevented by proper awareness camps. So, cancer detection and awareness camps are essential and important in rural areas to reduce the huge burden of cancer. Disclosure All authors have declared no conflicts of interest.